Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
4876 | 1640 | 34.1 | 85% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
233 | 19645 | BONE MARROW TRANSPLANTATION//GRAFT VERSUS HOST DISEASE//BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HAPLOIDENTICAL | Author keyword | 36 | 45% | 4% | 61 |
2 | NORMAL DONORS | Author keyword | 25 | 75% | 1% | 18 |
3 | T CELL DEPLETION | Author keyword | 20 | 24% | 4% | 73 |
4 | ALLODEPLETION | Author keyword | 18 | 83% | 1% | 10 |
5 | POOR GRAFT FUNCTION | Author keyword | 18 | 89% | 0% | 8 |
6 | HAPLOIDENTICAL TRANSPLANTATION | Author keyword | 16 | 50% | 1% | 23 |
7 | HEALTHY DONORS | Author keyword | 15 | 56% | 1% | 18 |
8 | HAPLOIDENTICAL STEM CELL TRANSPLANTATION | Author keyword | 13 | 49% | 1% | 20 |
9 | STEM CELL DONATION | Author keyword | 12 | 86% | 0% | 6 |
10 | ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION | Author keyword | 10 | 40% | 1% | 20 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | RISK ACUTE LEUKEMIA | 43 | 57% | 3% | 51 |
2 | ALLOGENEIC TRANSPLANTATION | 38 | 22% | 10% | 157 |
3 | POSTTRANSPLANTATION CYCLOPHOSPHAMIDE | 31 | 48% | 3% | 48 |
4 | HLA IDENTICAL SIBLINGS | 27 | 22% | 7% | 110 |
5 | LARGE SCALE METHOD | 27 | 83% | 1% | 15 |
6 | MISMATCHED PARENTAL DONORS | 23 | 86% | 1% | 12 |
7 | IDENTICAL SIBLING TRANSPLANTATION | 22 | 51% | 2% | 31 |
8 | HLA MISMATCHED HAPLOIDENTICAL BLOOD | 22 | 67% | 1% | 20 |
9 | FILGRASTIM MOBILIZATION | 15 | 82% | 1% | 9 |
10 | HEALTHY DONORS | 15 | 25% | 3% | 53 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Haploidentical hematopoietic transplantation: current status and future perspectives | 2011 | 52 | 91 | 48% |
Comparison of bone marrow versus peripheral blood allogeneic hematopoietic stem cell transplantation for hematological malignancies in adults-a systematic review and meta-analysis | 2015 | 1 | 34 | 74% |
Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project | 2007 | 79 | 39 | 59% |
Hematopoietic stem cell transplantation donor sources in the 21st century: choosing the ideal donor when a perfect match does not exist | 2014 | 13 | 84 | 35% |
Allogeneic transplantation: peripheral blood vs. bone marrow | 2012 | 13 | 43 | 77% |
Unmanipulated HLA-Mismatched/Haploidentical Blood and Marrow Hematopoietic Stem Cell Transplantation | 2011 | 16 | 52 | 71% |
Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter? | 2001 | 172 | 54 | 57% |
T-cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor | 2014 | 4 | 37 | 65% |
Post-Transplantation Cyclophosphamide for Tolerance Induction in HLA-Haploidentical Bone Marrow Transplantation | 2012 | 25 | 49 | 45% |
G-CSF in Healthy Allogeneic Stem Cell Donors | 2013 | 5 | 59 | 86% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BEIJING HEMATOPOIET STEM CELL TRANSPLANTA | 6 | 28% | 1.0% | 17 |
2 | NORWEGIAN BONE MARROW DONOR REGISTRY | 4 | 67% | 0.2% | 4 |
3 | ALLOTRANSPLANTAT SECT | 3 | 100% | 0.2% | 3 |
4 | STEM CELL TRANSPLANT PROGRAMHEMATOL | 2 | 67% | 0.1% | 2 |
5 | INT GREFFES MOELLE | 2 | 50% | 0.2% | 3 |
6 | FLOW CYTOMETR STUDY BLOOD CELLS | 2 | 43% | 0.2% | 3 |
7 | STEM CELL TRANSPLANT UNIT | 1 | 11% | 0.7% | 12 |
8 | CLIN BONE MARROW TRANSPLANTAT | 1 | 38% | 0.2% | 3 |
9 | ADULT BONE MARROW STEM CELL TRANSPLANTAT PROGRA | 1 | 50% | 0.1% | 2 |
10 | BRITISH BONE MARROW REGISTRY | 1 | 50% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000225603 | REDUCED INTENSITY CONDITIONING//DONOR LYMPHOCYTE INFUSION//REDUCED INTENSITY |
2 | 0.0000185265 | PLERIXAFOR//LARGE VOLUME LEUKAPHERESIS//STEM CELL MOBILIZATION |
3 | 0.0000157396 | TRANSPLANT RATES//EBMT ACT SURVEY OFF//OPERAT COMPUTAT FINANCE |
4 | 0.0000134464 | LYMPHOCYTE RECOVERY//IMMUNE RECONSTITUTION//BMT RECIPIENTS |
5 | 0.0000127764 | VETO CELLS//VETO//L LEUCYL L LEUCINE METHYL ESTER |
6 | 0.0000126724 | GRAFT VERSUS HOST DISEASE//CHRONIC GRAFT VERSUS HOST DISEASE//GVHD |
7 | 0.0000106887 | CORD BLOOD TRANSPLANTATION//UMBILICAL CORD BLOOD//CORD BLOOD |
8 | 0.0000105233 | INT TRANSPLANTAT THALASSEMIA SICKLE CELL AN//MEDITERRANEAN HEMATOL//TR IANTO MIDOLLO OSSEO MURAGLIA |
9 | 0.0000086851 | DONOR CELL LEUKEMIA//CHIMERISM//STR PCR |
10 | 0.0000077834 | GRANULOCYTE TRANSFUSION//GRANULOCYTE TRANSFUSIONS//GRANULOCYTE CONCENTRATES |